NCT07435168 CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis
| NCT ID | NCT07435168 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rigshospitalet, Denmark |
| Condition | Cardiac Amyloidosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2027-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2024-04-01 with a primary completion date of 2027-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this observational, prospective study is to determine the prevalence of Cardiac Amyloidosis (CA) in males over the age of 65 who experience chest pain but show no signs of coronary artery disease (CAD). Prior to inclusion, all patients will have undergone a CT coronary angiogram or an Rb-PET scan to rule out the possibility of CAD. Participants will be subject to several examinations, including blood tests, urine samples, ECG, echocardiography, and bone scintigraphy. An endomyocardial biopsy may be conducted if necessary.
Eligibility Criteria
Inclusion Criteria: No signs of CAD through Rb-PET and/or CT coronary arteriogram Exclusion Criteria: Previous history of amyloidosis
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07435168 clinical trial?
This trial is open to male participants only, aged 65 Years or older, studying Cardiac Amyloidosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07435168 currently recruiting?
Yes, NCT07435168 is actively recruiting participants. Contact the research team at navid.noory@regionh.dk for enrollment information.
Where is the NCT07435168 trial being conducted?
This trial is being conducted at Copenhagen, Denmark.
Who is sponsoring the NCT07435168 clinical trial?
NCT07435168 is sponsored by Rigshospitalet, Denmark. The trial plans to enroll 300 participants.